HAPPE Spine
Powering Next-Gen Orthopedic Implants
How LSO’s meticulous processing enables HAPPE Spine’s innovative INTEGRATE®-C implants to scale confidently and serve many HAPPE patients and healthcare providers.
Partnership Snapshot
Customer:
HAPPE Spine
Partnership Duration:
5 Years
Services Provided:
Wash-Clean, Package, Label, Gamma Sterilize, Ship
Milestones:
2021 – First of 11 issued patents to date
2022 – Validations completed and 510(k) submission
2023 – FDA 501(k) clearance and first-in-human
2023 – Orthopaedics This Week Best New Spine Technology Award
2025 – MedTech Innovator Cohort selection (top 4% of 1,500 global applicants)
2025 – 1,000 HAPPE patients!
Challenge & Opportunity
HAPPE Spine needed a world-class CMO partner to ensure their innovative interbody spinal fusion implants—built around their proprietary HAPPE® material—could be consistently processed with uncompromising quality, supporting continuous growth in demand.
LSO’s Solution
LSO delivers the full spectrum of mobilization and logistics for HAPPE’s implants:
- Precision Wash-Cleaning — ensuring sterile surfaces free from contaminants.
- Custom Packaging & Labeling — supporting traceability and compliance.
- Gamma Sterilization — validating each implant meets stringent safety specs.
- Reliable Shipping — to end the HAPPE distribution team
LSO’s ability to scale responsively, uphold regulatory standards, and maintain turnaround confidence has freed HAPPE to focus on innovation and growth.
Results
- Operational Peace of Mind: LSO handles sterilization and logistics flawlessly, even as volumes shift.
- Quality & Compliance Assurance: Every implant is processed to meet FDA-ready standards.
- Strategic Growth Alignment: LSO’s reliability enables HAPPE to invest confidently in product development and portfolio expansion.
Funding + Growth Context
- Closed Seed, Series A, and an oversubscribed Bridge funding round.
- Capital efficient operations.
- Strong commercial traction.
This financial foundation has enabled HAPPE to bring an innovative product to market for clinical validation of its proprietary biomaterial platform and scale its proprietary manufacturing operations to meet commercial demand while relying on LSO as a steadfast supply chain partner.
Discover how LSO empowers orthopedic innovators to grow without logistics limits. Let’s talk.